# ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography

> **NCT01594736** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 30 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** ORSIRO
- **DEVICE:** XIENCE PRIME DES

## Key facts

- **NCT ID:** NCT01594736
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01594736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01594736, "ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01594736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
